These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 37566126

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
    Yilmaz B, Somay E, Topkan E, Kucuk A, Pehlivan B, Selek U.
    BMC Oral Health; 2023 Apr 20; 23(1):231. PubMed ID: 37081475
    [Abstract] [Full Text] [Related]

  • 5. Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
    Somay E, Topkan E, Kucuk A, Ozturk D, Ozkan EE, Ozdemir BS, Besen AA, Mertsoylu H, Pehlivan B, Selek U.
    J Stomatol Oral Maxillofac Surg; 2024 Jun 20; 125(3S):101838. PubMed ID: 38518893
    [Abstract] [Full Text] [Related]

  • 6. Prognostic Value of Pre-Chemoradiotherapy Pan-Immune-Inflammation Value (PIV) in Locally Advanced Nasopharyngeal Cancers.
    Topkan E, Selek U, Ozturk D, Şenyürek Ş, Kılıç Durankuş N.
    Cancer Control; 2024 Jun 20; 31():10732748241290746. PubMed ID: 39361825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
    Yilmaz B, Somay E, Selek U, Topkan E.
    Ther Clin Risk Manag; 2021 Jun 20; 17():1113-1121. PubMed ID: 34703240
    [Abstract] [Full Text] [Related]

  • 12. Global Immune-Nutrition-Inflammation Index as a novel comprehensive biomarker in predicting the radiation-induced trismus rates in locally advanced nasopharyngeal carcinoma patients.
    Somay E, Topkan E, Bascil S, Kılıc Durankuş N, Senyürek Ş, Ozturk D, Pehlivan B, Selek U.
    Biomol Biomed; 2024 Oct 17; 24(6):1703-1710. PubMed ID: 38860864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
    Topkan E, Somay E, Yilmaz B, Pehlivan B, Selek U.
    BMC Cancer; 2023 Jul 12; 23(1):651. PubMed ID: 37438683
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide.
    Topkan E, Kucuk A, Selek U.
    J Immunol Res; 2022 Jul 12; 2022():1346094. PubMed ID: 36479136
    [Abstract] [Full Text] [Related]

  • 17. A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer.
    Kucuk A, Topkan E, Ozkan EE, Ozturk D, Pehlivan B, Selek U.
    Int J Immunopathol Pharmacol; 2023 Jul 12; 37():3946320231187759. PubMed ID: 37404137
    [Abstract] [Full Text] [Related]

  • 18. Is Dose Volume a Better Predictor of Osteoradionecrosis Risk Than Total Dose for Patients Who Have Received Head and Neck Radiation?
    DeLuke D, Carrico C, Ray C, Stilianoudakis S, Holler S, Padilla L, Song S.
    J Oral Maxillofac Surg; 2022 Sep 12; 80(9):1557-1563. PubMed ID: 35594907
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
    Pehlivan UA, Somay E, Yilmaz B, Besen AA, Mertsoylu H, Selek U, Topkan E.
    J Clin Med; 2023 Oct 30; 12(21):. PubMed ID: 37959329
    [Abstract] [Full Text] [Related]

  • 20. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations.
    Aarup-Kristensen S, Hansen CR, Forner L, Brink C, Eriksen JG, Johansen J.
    Acta Oncol; 2019 Oct 30; 58(10):1373-1377. PubMed ID: 31364903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.